Research progress of Candida albicans on malignant transformation of oral mucosal diseases

doi:10.7518/hxkq.2020.04.014

Abstract

Abstract:

Oral cancer is the most common malignant tumor in the head and neck, and is one of the world’s top ten malignancies. Microbial infection is an important risk factor of oral cancer. Candida albicans is the most popular opportunistic fungal pathogen. Epidemiological studies have shown that Candida albicans is closely tied to oral malignancy. Animal experimentation have also proven that infection of Candida albicans can promote the development of oral epithelial carcinogenesis. The current studies have revealed several mechanisms involved in this process, including destroying the epithelial barrier, producing carcinogenic substances (nitrosamines, acetaldehyde), inducing chronic inflammation, activating immune response, etc. However, current researches on mechanisms are still inadequate, and some hypotheses remain controversial. Here, we review the findings related to Candida albicans’ effect on the malignant transformation of oral mucosa, hoping to provide reference for deep research and controlling oral cancer clinically.

Key words: Candida albicans, oral cancer, nitrosamines, acetaldehyde, inflammation, interleukin-17

CLC Number:

R780.2

Liao Min, Cheng Lei, Zhou Xuedong, Ren Biao. Research progress of Candida albicans on malignant transformation of oral mucosal diseases[J]. West China Journal of Stomatology, 2020, 38(4): 431-437.

Figures/Tables 1

References 62

[1]	Zhang SK, Zheng R, Chen Q, et al. Oral cancer incidence and mortality in China, 2011[J]. Chin J Cancer Res, 2015,27(1):44-51.
[2]	Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014[J]. CA Cancer J Clin, 2014,64(1):9-29. doi: 10.3322/caac.21208 URL pmid: 24399786
[3]	Zini A, Czerninski R, Sgan-Cohen HD. Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites[J]. J Oral Pathol Med, 2010,39(4):299-305. URL pmid: 20040019
[4]	Messadi DV. Diagnostic aids for detection of oral precancerous conditions[J]. Int J Oral Sci, 2013,5(2):59-65. doi: 10.1038/ijos.2013.24 URL pmid: 23743617
[5]	Wu TS, Tan CT, Chang CC, et al. B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway[J]. Oncogene, 2015,34(10):1207-1219.
[6]	Chinn SB, Myers JN. Oral cavity carcinoma: current management, controversies, and future directions[J]. J Clin Oncol, 2015,33(29):3269-3276. doi: 10.1200/JCO.2015.61.2929 URL pmid: 26351335
[7]	Feller L, Lemmer J. Oral squamous cell carcinoma: epidemiology, clinical presentation and treatment[J]. J Cancer Ther, 2012,3(4):263-268.
[8]	Meurman JH. Infectious and dietary risk factors of oral cancer[J]. Oral Oncol, 2010,46(6):411-413. URL pmid: 20381409
[9]	Parkin DM. The global health burden of infection-associated cancers in the year 2002[J]. Int J Cancer, 2006,118(12):3030-3044. URL pmid: 16404738
[10]	de Martel C, Franceschi S. Infections and cancer: established associations and new hypotheses[J]. Crit Rev Oncol Hematol, 2009,70(3):183-194.
[11]	Lucchese A. Viruses and oral cancer: crossreactivity as a potential link[J]. Anticancer Agents Med Chem, 2015,15(10):1224-1229. doi: 10.2174/1871520615666150716105654 URL pmid: 26179264
[12]	Inaba H, Sugita H, Kuboniwa M, et al. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation[J]. Cell Microbiol, 2014,16(1):131-145. URL pmid: 23991831
[13]	Kang J, He Y, Hetzl D, et al. A candid assessment of the link between oral Candida containing biofilms and oral cancer[J]. Adv Microbiol, 2016,6(2):115-123.
[14]	Cawson RA. Leukoplakia and oral cancer[J]. Proc Royal Soc Med, 1969,62(6):610-615.
[15]	陈谦明. 口腔黏膜病学[M]. 4版. 北京: 人民卫生出版社, 2015: 36-38.
	Chen QM. Diseases of the oral mucosa[M]. 4th ed. Beijing: People’s Medical Publishing House, 2015: 36-38.
[16]	Chocolatewala N, Chaturvedi P, Desale R. The role of bacteria in oral cancer[J]. Indian J Med Paediatr Oncol, 2010,31(4):126-131.
[17]	Mohd Bakri M, MohdHussaini H, Rachel Holmes A, et al. Revisiting the association between candidal infection and carcinoma, particularly oral squamous cell carcinoma[J]. J Oral Microbiol, 2010,2(1):5780. doi: 10.3402/jom.v2i0.5780 URL
[18]	Bartie KL, Williams DW, Wilson MJ, et al. Differential invasion of Candida albicans isolates in an in vitro model of oral candidosis[J]. Oral Microbiol Immunol, 2004,19(5):293-296. doi: 10.1111/j.1399-302X.2004.00155.x URL pmid: 15327640
[19]	Lewis MAO, Williams DW. Diagnosis and management of oral candidosis[J]. Br Dent J, 2017,223(9):675-681. doi: 10.1038/sj.bdj.2017.886 URL pmid: 29123282
[20]	Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics[J]. Crit Rev Oral Biol Med, 2003,14(1):47-62. doi: 10.1177/154411130301400105 URL pmid: 12764019
[21]	Nieminen MT, Uittamo J, Salaspuro M, et al. Acetaldehyde production from ethanol and glucose by non-Candida albicans yeasts in vitro[J]. Oral Oncol, 2009,45(12):e245-e248. URL pmid: 19793674
[22]	Rautemaa R, Hietanen J, Niissalo S, et al. Oral and oesophageal squamous cell carcinoma: a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I)[J]. Oral Oncol, 2007,43(6):607-613. doi: 10.1016/j.oraloncology.2006.07.005 URL pmid: 16997613
[23]	Chung LM, Liang J, Lin CL, et al. Cancer risk in patients with candidiasis: a nationwide population-based cohort study[J]. Oncotarget, 2017,8(38):63562-63573. URL pmid: 28969011
[24]	Mäkinen A, Nawaz A, Mäkitie A, et al. Role of non-albicans Candida and Candida albicans in oral squamous cell cancer patients[J]. J Oral Maxillofac Surg, 2018,76(12):2564-2571. URL pmid: 30509395
[25]	Perera M, Al-Hebshi NN, Perera I, et al. A dysbiotic mycobiome dominated by Candida albicans is identified within oral squamous-cell carcinomas[J]. J Oral Microbiol, 2017,9(1):1385369. URL pmid: 29152157
[26]	Alnuaimi AD, Wiesenfeld D, O’Brien-Simpson NM, et al. Oral Candida colonization in oral cancer patients and its relationship with traditional risk factors of oral cancer: a matched case-control study[J]. Oral Oncol, 2015,51(2):139-145. URL pmid: 25498921
[27]	McCullough M, Jaber M, Barrett AW, et al. Oral yeast carriage correlates with presence of oral epithelial dysplasia[J]. Oral Oncol, 2002,38(4):391-393. doi: 10.1016/s1368-8375(01)00079-3 URL pmid: 12076705
[28]	Dwivedi PP, Mallya S, Dongari-Bagtzoglou A. A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia[J]. Med Mycol, 2009,47(2):157-167. URL pmid: 18608888
[29]	Allert S, Förster TM, Svensson CM, et al. Candida albicans-induced epithelial damage mediates translocation through intestinal barriers[J]. mBio, 2018,9(3):e00915-e00918. doi: 10.1128/mBio.00915-18 URL pmid: 29871918
[30]	Naglik JR, König A, Hube B, et al. Candida albicans-epithelial interactions and induction of mucosal innate immunity[J]. Curr Opin Microbiol, 2017,40:104-112. doi: 10.1016/j.mib.2017.10.030 URL pmid: 29156234
[31]	Richardson JP, Ho J, Naglik JR. Candida-epithelial interactions[J]. J Fungi (Basel), 2018,4(1):E22.
[32]	Villar CC, Kashleva H, Nobile CJ, et al. Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p[J]. Infect Immun, 2007,75(5):2126-2135. doi: 10.1128/IAI.00054-07 URL pmid: 17339363
[33]	Swidergall M, Filler SG. Oropharyngeal candidiasis: fungal invasion and epithelial cell responses[J]. PLoS Pathog, 2017,13(1):e1006056. doi: 10.1371/journal.ppat.1006056 URL pmid: 28081240
[34]	Pärnänen P, Kari K, Virtanen I, et al. Human laminin-332 degradation by Candida proteinases[J]. J Oral Pathol Med, 2008,37(6):329-335. doi: 10.1111/j.1600-0714.2008.00638.x URL pmid: 18284540
[35]	Moyes DL, Wilson D, Richardson JP, et al. Candidalysin is a fungal peptide toxin critical for mucosal infection[J]. Nature, 2016,532(7597):64-68. doi: 10.1038/nature17625 URL pmid: 27027296
[36]	Ramirez-Garcia A, Rementeria A, Aguirre-Urizar JM, et al. Candida albicans and cancer: can this yeast induce cancer development or progression[J]. Crit Rev Microbiol, 2016,42(2):181-193. doi: 10.3109/1040841X.2014.913004 URL pmid: 24963692
[37]	Krogh P, Hald B, Holmstrup P. Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine[J]. Carcinogenesis, 1987,8(10):1543-1548. doi: 10.1093/carcin/8.10.1543 URL pmid: 3652390
[38]	Delsing CE, Bleeker-Rovers CP, van de Veerdonk FL, et al. Association of esophageal candidiasis and squamous cell carcinoma[J]. Med Mycol Case Rep, 2012,1(1):5-8. doi: 10.1016/j.mmcr.2012.02.003 URL pmid: 24371724
[39]	Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systematic review of the literature[J]. Head Neck, 2009,31(9):1228-1239. doi: 10.1002/hed.21140 URL pmid: 19475550
[40]	Sanjaya PR, Gokul S, Gururaj Patil B, et al. Candida in oral pre-cancer and oral cancer[J]. Med Hypotheses, 2011,77(6):1125-1128. doi: 10.1016/j.mehy.2011.09.018 URL pmid: 21978967
[41]	Gainza-Cirauqui ML, Nieminen MT, Novak Frazer L, et al. Production of carcinogenic acetaldehyde by Candida albicans from patients with potentially malignant oral mucosal disorders[J]. J Oral Pathol Med, 2013,42(3):243-249. doi: 10.1111/j.1600-0714.2012.01203.x URL pmid: 22909057
[42]	Alnuaimi AD, Ramdzan AN, Wiesenfeld D, et al. Candida virulence and ethanol-derived acetaldehyde production in oral cancer and non-cancer subjects[J]. Oral Dis, 2016,22(8):805-814. doi: 10.1111/odi.12565 URL pmid: 27495361
[43]	Manzo-Avalos S, Saavedra-Molina A. Cellular and mitochondrial effects of alcohol consumption[J]. Int J Environ Res Public Health, 2010,7(12):4281-4304. doi: 10.3390/ijerph7124281 URL pmid: 21318009
[44]	Seitz HK, Stickel F. Acetaldehyde as an underestimated risk factor for cancer development: role of genetics in ethanol metabolism[J]. Genes Nutr, 2010,5(2):121-128. doi: 10.1007/s12263-009-0154-1 URL pmid: 19847467
[45]	Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow[J]. Lancet, 2001,357(9255):539-545. doi: 10.1016/S0140-6736(00)04046-0 URL pmid: 11229684
[46]	Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents[J]. Nat Rev Clin Oncol, 2015,12(10):584-596. doi: 10.1038/nrclinonc.2015.105 URL
[47]	Shalapour S, Karin M. Immunity, inflammation, and cancer: an eternal fight between good and evil[J]. J Clin Invest, 2015,125(9):3347-3355. doi: 10.1172/JCI80007 URL pmid: 26325032
[48]	Wang F, Arun P, Friedman J, et al. Current and potential inflammation targeted therapies in head and neck cancer[J]. Curr Opin Pharmacol, 2009,9(4):389-395. doi: 10.1016/j.coph.2009.06.005 URL
[49]	Deva R, Shankaranarayanan P, Ciccoli R, et al. Candida albicans induces selectively transcriptional activation of cyclooxygenase-2 in HeLa cells: pivotal roles of Toll-like receptors, p38 mitogen-activated protein kinase, and NF-kappa B[J]. J Immunol, 2003,171(6):3047-3055. doi: 10.4049/jimmunol.171.6.3047 URL pmid: 12960330
[50]	Whiley RA, Cruchley AT, Gore C, et al. Candida albicans strain-dependent modulation of pro-inflammatory cytokine release by in vitro oral and vaginal mucosal models[J]. Cytokine, 2012,57(1):89-97. doi: 10.1016/j.cyto.2011.10.017 URL
[51]	Yang SF, Chen MK, Hsieh YS, et al. Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells[J]. J Biol Chem, 2010,285(39):29808-29816. doi: 10.1074/jbc.M110.108183 URL pmid: 20647315
[52]	Shrihari TG. Dual role of inflammatory mediators in cancer[J]. Ecancermedicalscience, 2017,11:721. doi: 10.3332/ecancer.2017.721 URL pmid: 28275390
[53]	Inada M, Takita M, Yokoyama S, et al. Direct melanoma cell contact induces stromal cell autocrine prostaglandin E2-EP4 receptor signaling that drives tumor growth, angiogenesis, and metastasis[J]. J Biol Chem, 2015,290(50):29781-29793. doi: 10.1074/jbc.M115.669481 URL pmid: 26475855
[54]	Nakanishi M, Rosenberg DW. Multifaceted roles of PGE₂ in inflammation and cancer[J]. Semin Immunopathol, 2013,35(2):123-137. doi: 10.1007/s00281-012-0342-8 URL
[55]	Claveau I, Mostefaoui Y, Rouabhia M. Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans[J]. Matrix Biol, 2004,23(7):477-486. doi: 10.1016/j.matbio.2004.08.006 URL pmid: 15579314
[56]	Fan HX, Li HX, Chen D, et al. Changes in the expression of MMP2, MMP9, and ColⅣ in stromal cells in oral squamous tongue cell carcinoma: relationships and prognostic implications[J]. J Exp Clin Cancer Res, 2012,31(1):90. doi: 10.1186/1756-9966-31-90 URL
[57]	Conti HR, Peterson AC, Brane L, et al. Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections[J]. J Exp Med, 2014,211(10):2075-2084. doi: 10.1084/jem.20130877 URL
[58]	Verma AH, Richardson JP, Zhou CS, et al. Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin[J]. Sci Immunol, 2017,2(17):8834.
[59]	Murugaiyan G, Saha B. Protumor vs antitumor functions of IL-17[J]. J Immunol, 2009,183(7):4169-4175. doi: 10.4049/jimmunol.0901017 URL pmid: 19767566
[60]	Lee MH. Abstract 441: IL-17 and IL-17-producing cells associated with advanced stage or poor prognosis in oral cancers, through enhancing tumor progression[J]. Cancer Research, 2015,75:441.
[61]	Xiang T, Long H, He L, et al. Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer[J]. Oncogene, 2015,34(2):165-176. doi: 10.1038/onc.2013.537 URL pmid: 24362529
[62]	Jiang YX, Yang SW, Li PA, et al. The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms[J]. Oncogene, 2017,36(9):1256-1264. doi: 10.1038/onc.2016.291 URL pmid: 27524415